10 clinical trials to watch in the second half of 2022
Bio Pharma Dive
JULY 4, 2022
The biotech industry's downturn accelerated in the first half of the year. Important study readouts for Eisai, Gilead, Merck and Seagen, among others, could determine whether the slump will endure.
Let's personalize your content